1. Survivin in Breast Cancer: A Review
   Manuel Antonio Martínez-Sifuentes et al, 2022, Genetic Testing and Molecular Biomarkers CrossRef
2. Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells
   Ewa Jasek-Gajda et al, 2019, Apoptosis CrossRef
3. Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells
   Daniela León et al, 2020, International Journal of Molecular Sciences CrossRef
4. A Highly Effective System for Predicting MHC-II Epitopes With Immunogenicity
   Shi Xu et al, 2022, Frontiers in Oncology CrossRef
5. B7-H3/CD276: An Emerging Cancer Immunotherapy
   Wu-Tong Zhou et al, 2021, Frontiers in Immunology CrossRef
6. Antitumor Activity of Piceamycin by Upregulation of N-Myc Downstream-Regulated Gene 1 in Human Colorectal Cancer Cells
   Kay Zin Kyaw et al, 2022, Journal of Natural Products CrossRef
7. RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies
   Navid Shomali et al, 2022, Frontiers in Immunology CrossRef
8. Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case–control studies
   Abdolkarim Moazeni-Roodi et al, 2019, International Journal of Clinical Oncology CrossRef
9. The novel non‐immunological role and underlying mechanisms of B7‐H3 in tumorigenesis
   Xiangqi Zhou et al, 2019, Journal of Cellular Physiology CrossRef
10. Anticancer activities of Brachydin C in human prostate tumor cells (DU145) grown in 2D and 3D models: Stimulation of cell death and downregulation of metalloproteinases in spheroids
    Larissa Cristina Bastos de Oliveira et al, 2022, Chemical Biology & Drug Design CrossRef
11. Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression
    Swaroop Kumar Pandey et al, 2022, Frontiers in Oncology CrossRef
12. Dominant-negative ATF5 rapidly depletes survivin in tumor cells
    Xiaotian Sun et al, 2019, Cell Death & Disease CrossRef
13. Borealin-Derived Peptides as Survivin-Targeting Cancer Imaging and Therapeutic Agents
    Iori Nozaki et al, 2022, Bioconjugate Chemistry CrossRef
14. Decreased BIRC5-206 promotes epithelial–mesenchymal transition in nasopharyngeal carcinoma through sponging miR-145-5p
    Weihua Xu et al, 2024, Open Medicine CrossRef
15. Anti-tumor Effects of Cisplatin Synergist in Combined Treatment with Clostridium novyi-NT Spores Against Hypoxic Microenvironments in a Mouse Model of Cervical Cancer Caused by TC-1 Cell Line
    Behrouz Ebadi Sharafabad et al, 2023, Advanced Pharmaceutical Bulletin CrossRef
16. New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia
    Stephanie Jordaens et al, 2020, Cancer Immunology, Immunotherapy CrossRef